[go: up one dir, main page]

BR9908427A - Composições farmacêuticas e uso das mesmas - Google Patents

Composições farmacêuticas e uso das mesmas

Info

Publication number
BR9908427A
BR9908427A BR9908427-9A BR9908427A BR9908427A BR 9908427 A BR9908427 A BR 9908427A BR 9908427 A BR9908427 A BR 9908427A BR 9908427 A BR9908427 A BR 9908427A
Authority
BR
Brazil
Prior art keywords
pharmaceutical compositions
component
compounds containing
ulcer
components
Prior art date
Application number
BR9908427-9A
Other languages
English (en)
Inventor
Piero Del Soldato
Original Assignee
Nicox Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicox Sa filed Critical Nicox Sa
Publication of BR9908427A publication Critical patent/BR9908427A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"COMPOSIçõES FARMACêUTICAS E USO DAS MESMAS" Composições farmacêuticas para terapia e prevenção de recorrências de úlcera e dispepsia contendo como componentes essenciais os seguintes componentes a) e b): componente a): um ou mais componentes selecionados entre os produtos conta úlcera convencionais; componente b) compostos orgânicos contendo a função -ONO~ 2~, ou compostos inorgânicos contendo o grupo -NO, caracterizados por serem doadores de óxido nítrico NO.
BR9908427-9A 1998-03-05 1999-02-25 Composições farmacêuticas e uso das mesmas BR9908427A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT98MI000443A IT1298338B1 (it) 1998-03-05 1998-03-05 Composizioni farmaceutiche per l'ulcera
PCT/EP1999/001225 WO1999044595A2 (en) 1998-03-05 1999-02-25 Pharmaceutical compositions for ulcer

Publications (1)

Publication Number Publication Date
BR9908427A true BR9908427A (pt) 2000-10-31

Family

ID=11379187

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9908427-9A BR9908427A (pt) 1998-03-05 1999-02-25 Composições farmacêuticas e uso das mesmas

Country Status (17)

Country Link
US (2) US6436975B1 (pt)
EP (1) EP1083887B1 (pt)
JP (1) JP2002505276A (pt)
KR (1) KR100579810B1 (pt)
CN (1) CN1210027C (pt)
AT (1) ATE305791T1 (pt)
AU (1) AU757155B2 (pt)
BR (1) BR9908427A (pt)
CA (1) CA2322865C (pt)
DE (1) DE69927584T2 (pt)
DK (1) DK1083887T3 (pt)
ES (1) ES2251180T3 (pt)
HU (1) HUP0203648A3 (pt)
IL (1) IL137722A0 (pt)
IT (1) IT1298338B1 (pt)
RU (1) RU2227030C2 (pt)
WO (1) WO1999044595A2 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU772188B2 (en) 1998-11-17 2004-04-08 Nitromed, Inc. Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use
US6852739B1 (en) * 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
IL150368A0 (en) 1999-12-23 2002-12-01 Nitromed Inc Nitrosated and nitrosylated cyclooxygenase-2-inhibitors, compositions and methods of use
SE0002476D0 (sv) 2000-06-30 2000-06-30 Astrazeneca Ab New compounds
US6706724B2 (en) 2000-12-21 2004-03-16 Nitromed, Inc. Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use
CA2487414A1 (en) 2002-06-11 2003-12-18 Nitromed, Inc. Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
JP2005539089A (ja) 2002-07-03 2005-12-22 ニトロメッド インコーポレーティッド ニトロソ化非ステロイド性抗炎症化合物、組成物および使用方法
JP2005538110A (ja) 2002-07-29 2005-12-15 ニトロメッド インコーポレーティッド シクロオキシゲナーゼ−２選択的阻害剤、組成物、および使用方法
AU2003254282A1 (en) * 2002-08-01 2004-02-23 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
CA2912259C (en) 2005-05-27 2020-04-28 Mark H. Schoenfisch Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
WO2010044875A2 (en) * 2008-10-16 2010-04-22 Novan, Inc. Nitric oxide releasing particles for oral care applications
US9919072B2 (en) 2009-08-21 2018-03-20 Novan, Inc. Wound dressings, methods of using the same and methods of forming the same
EP4249001A3 (en) 2009-08-21 2023-11-29 Novan, Inc. Topical gels
EP2488591A1 (en) * 2009-10-13 2012-08-22 Novan, Inc. Nitric oxide-releasing coatings
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
ES2695173T3 (es) 2011-02-28 2019-01-02 Novan Inc Partículas de sílice modificadas con S-nitrosotiol que liberan óxido nítrico y procedimientos de fabricación de las mismas
RU2539630C1 (ru) * 2013-07-09 2015-01-20 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ профилактики ишемии сетчатки в эксперименте

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995009831A1 (en) * 1993-10-06 1995-04-13 Nicox S.A. Nitric esters having anti-inflammatory and/or analgesic activity and process for their preparation
IT1282686B1 (it) * 1996-02-26 1998-03-31 Nicox Sa Composti in grado di ridurre la tossicita' da farmaci

Also Published As

Publication number Publication date
US20030027844A1 (en) 2003-02-06
AU2726399A (en) 1999-09-20
RU2227030C2 (ru) 2004-04-20
ES2251180T3 (es) 2006-04-16
CA2322865C (en) 2009-12-08
DK1083887T3 (da) 2006-01-16
AU757155B2 (en) 2003-02-06
IT1298338B1 (it) 1999-12-20
US6436975B1 (en) 2002-08-20
WO1999044595A3 (en) 1999-11-25
EP1083887A2 (en) 2001-03-21
KR20010034547A (ko) 2001-04-25
IL137722A0 (en) 2001-10-31
ITMI980443A1 (it) 1999-09-05
WO1999044595A2 (en) 1999-09-10
CN1291896A (zh) 2001-04-18
CA2322865A1 (en) 1999-09-10
DE69927584D1 (de) 2006-02-16
HUP0203648A2 (hu) 2003-02-28
HUP0203648A3 (en) 2006-07-28
ATE305791T1 (de) 2005-10-15
CN1210027C (zh) 2005-07-13
DE69927584T2 (de) 2006-07-13
EP1083887B1 (en) 2005-10-05
JP2002505276A (ja) 2002-02-19
KR100579810B1 (ko) 2006-05-12

Similar Documents

Publication Publication Date Title
BR9908427A (pt) Composições farmacêuticas e uso das mesmas
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
PT1073470E (pt) Composicoes farmaceuticas contendo compostos com actividade capaz de melhorar a absorcao de ingredientes activos
NO180538C (no) N-sulfonyl-2-oksoindol-derivater som har affinitet for vasopressin- og/eller ocytocin-reseptorer, farmasöytiske blandinger som inneholder dem og mellomprodukter ved fremstilling av derivatene
MX9202407A (es) Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion.
HK5783A (en) Substituted propanolamine and morpholine derivatives
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
BR9811249A (pt) Nova formulação para inalação; apresentando densidade volumétrica, quando derramada, de 0,20 à 0,38g/ml, processo para preparação de formulação e uso da mesma
BR9707739A (pt) Utilizacão de compostos orgânicos
BR0112030A (pt) Novos compostos que possuem atividade antibacteriana, antifúngica ou antitumor
NO903925D0 (no) Fremgangsmaate for fremstilling av 3-(1-substituert-4-piperazinyl)-1h-indazoler samt anvendelse som legemidler.
BR9910573A (pt) Compostos antipicornavirais, preparação e uso dos mesmos
ES2192832T3 (es) Uso de compuestos macrolidos para tratar glaucoma.
ATE265535T1 (de) Pharmazeutische zusammensetzung gegen durch papillomaviren verursachte tumoren und infektionen
KR890015742A (ko) 이병치료용 국소 제제
ES2076595T3 (es) Derivados de amidinofenilalanina, procedimiento para su preparacion, su empleo y agentes que los contienen.
OA07525A (fr) Dérivés d'acides-animés, leur préparation et utilisation ainsi que les compositions contenant ces dérivés.
TR26619A (tr) YENI BILESIKLER,BUNLARIN HAZIRLANMALARINA YÖNELIK ISLEMLER,BUNLARI ICEREN BILESIMLER VE BUNLARIN ZARARLI OT ÖLDüRüCüSü(HERBISIDAL) OLARAK KULLANI- MI.
DE60116106D1 (de) Benzofuran derivate und ihre verwendung als antibakterielle wirkstoffe
ES2196840T3 (es) Uso de compuestos macrolidos para el tratamiento de lesiones pulmonares agudas.
CL2004001291A1 (es) Composicion farmaceutica que comprende compuestos carbociclicos y heterociclicos; y su uso para el tratamiento o profilaxis de la infeccion por influenza.
DK11089D0 (da) 2,5-diazabicyclooe2.2.1aaheptan-forbindelser, deres anvendelse til fremstilling af antiarytmi-laegemidler, farmaceutiske praeparater indeholdende forbindelserne samt forbindelse til anvendelse som udgangsmateriale ved deres fremstilling
AR008474A1 (es) Derivado de 9-dihidroeritromicina a 6,9; 11,12-diciclocarbonato, composicion farmaceutica y preparacion bactericida que lo contienen y su uso
BR9812002A (pt) Compostos com efeito antiprimeiro-passe
FR2694292B1 (fr) Dérivés de benzimidazole-2-thione-, leur préparation et leur application en tant que médicament.

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: NICOX S.A. (FR)

Free format text: ANOTADAS AS ALTERACOES DE SEDE CONFORME SOLICITADO NA PETICAO NO 020050046572/RJ DE 06/06/2005.

B25G Requested change of headquarter approved

Owner name: NICOX S.A. (FR)

Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 020070016104/RJ DE 07/02/2007.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL: A61K 31/00, A61K 31/04, A61K 31/40, A61K 31/41, A61K 31/4164, A61K 31/4184, A61K 31/42, A61K 31/426, A61P 1/04

Ipc: A61K 31/00 (2008.01), A61K 31/04 (2008.01), A61K 3

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO, UMA VEZ QUE INFRINGE OS ARTIGOS 8O E 13 DA LEI 9279/96

B12B Appeal against refusal [chapter 12.2 patent gazette]